Prosonix Ltd (Oxford, UK), acknowledged leader in the commercialization of proprietary ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions for the pharmaceutical and related industries, have today successfully completed a £5 million total funding round designed to underpin and drive the accelerated future growth plans of the business.